The filtration manufacturer Pall Corp. of Port Washington has appointed a new chief technology officer.
Pall announced the hiring of Michael Egholm, 47, on Monday.
He most recently held a similar position at 454 Life Sciences, a division of Roche Applied Science. There, Egholm led the Neanderthal Sequencing project and the sequencing of the first individual human genome, Pall said in a news release.
Egholm's new duties at Pall will focus on tech research in the company's industrial and life sciences enterprises.
Eric Krasnoff, chairman and chief executive of Pall, said Egholm will "play a key role in our continuing mission to solve customers' most demanding fluid management challenges and keep Pall at the forefront of innovation."
While earning his Ph.D. in organic chemistry from the University of Copenhagen in Denmark Egholm was lead inventor of peptide nucleic acids technology, a synthetic form of DNA. He has published more than 100 papers in Science, Nature, The New England Journal of Medicine and elsewhere.
He is an elected member of the Royal Danish Academy of Sciences and Letters, and is the named inventor of 40 U.S. patents.
Read more of Inside Long Island Business